ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1295

A Qualitative Survey of Internal Medicine Residents’ Understanding of Appropriate ANA Testing: An 11-Year Update Since the ‘Choosing Wisely’ Campaign

Arushika Yedla1, Wei Tang2, Jaspreet Bhatti2, Kyu-In Lee3 and James Miceli3, 1Westchester Medical Center, White Plains, NY, 2Westchester Medical Center, Valhalla, 3Westchester Medical Center, Valhalla, NY

Meeting: ACR Convergence 2024

Keywords: Autoantibody(ies), autoimmune diseases, Disease Activity, education, medical, primary care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Professional Education Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: ANA testing is recommended when there is a reasonable clinical suspicion for systemic autoimmune disease. Testing in the setting of low pre-test probability, however, leads to unnecessary specialist referrals, subsequent testing, medical costs, and patient anxiety. An ACR ad hoc committee published recommendations regarding ANA testing in 2002. The American Board of Internal Medicine (ABIM) and ACR partnered in 2013 to provide more specific recommendations on this topic to minimize unnecessary testing. Yet, we hypothesized that today’s trainees are unaware of these recommendations. Our study aims to assess awareness of available ANA testing guidelines and the practice patterns among internal medicine residents at a large teaching hospital.

Methods: A 10-question Google survey was created and emailed to all internal medicine trainees at Westchester Medical Center. Trainees were instructed to answer all questions independently and without additional references. They were informed that their answers would be anonymized. Twenty-five (42%) of internal medicine residents responded, and their answers then collected and analyzed.

Results: 52% of trainees know that 1:80 is the correct cut-off for a positive ANA, but only 12% know that indirect immunofluorescence assay on HEp-2 cells is the preferred technique for measuring ANA. 72% are either “not at all” or “minimally” confident about knowing when to order ANA, and 36% can “never” or “rarely” interpret the results. 56% would include ANA in a workup for a patient with fatigue and myalgias, and 24% would check ANA serially in a patient with established SLE. Almost 70% feel that they have received contradictory instructions regarding ANA testing, and 0 respondents were able to identify any recommendations/guidelines regarding ANA.

Conclusion: Basic knowledge regarding ANA testing and appropriate interpretation is low among internal medicine house staff. No trainees were able to verbalize awareness of the ABIM’s Choosing Wisely Campaign and/or its recommendations, suggesting that a relaunch of this campaign may be warranted. Further, the high percentage of trainees reporting conflicting instruction pertaining to ANA suggests that clearer guidelines are needed.


Disclosures: A. Yedla: None; W. Tang: None; J. Bhatti: None; K. Lee: None; J. Miceli: None.

To cite this abstract in AMA style:

Yedla A, Tang W, Bhatti J, Lee K, Miceli J. A Qualitative Survey of Internal Medicine Residents’ Understanding of Appropriate ANA Testing: An 11-Year Update Since the ‘Choosing Wisely’ Campaign [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-qualitative-survey-of-internal-medicine-residents-understanding-of-appropriate-ana-testing-an-11-year-update-since-the-choosing-wisely-campaign/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-qualitative-survey-of-internal-medicine-residents-understanding-of-appropriate-ana-testing-an-11-year-update-since-the-choosing-wisely-campaign/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology